Aktiesnakken — November 2009
-
Ja hvis det er partnerens del, af et 2010 salg....
-
could generate $40 million in sales next year
-
så vidt jeg ved snakker bioporto først om 2011, så hvis de kan tjene på 40mil USD i 2010 på at producere det som bioporto sælger i 2010
-
så må det betyde store indtægter til bioporto allerede fra 2010 og frem... men det er naturligvis kun en spekulation
-
Nej ELISA produceres af bioporto selv... det er kun NGAL (homogen) som skal produceres i licens som jeg har forstået det
-
Thermo Fisher: http://www.thermofisher.com/global/en/about/home.asp
-
Biop> Seppo Olavi Mäkinen tidligere bestyrelses medlem? har også været bestyrelses medlem i Thermo fisher (side 90) http://antibodyshop.com/content/download/1030/33468/version/2/file/Announcement+09+2007.pdf
-
lyder spændende Kim
-
Forkert link. Her kommer der rigtige http://www.antibodyshop.dk/content/download/1019/33303/version/1/file/Meddelelse+20+2007.pdf
-
neuro... næsten fuldtegning... 96,7%
-
-
after meetings pliiing
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind